ResMed (RMD) returns
ResMed returns over 10 years
$1,000 invested in ResMed ten years ago was worth $4,259 at the close on October 30, 2026, with dividends reinvested: an average return of 15.6% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +4.0% | — | $1,040 | -0.9% |
| 3 months | +10.6% | — | $1,106 | +2.1% |
| Year to date | -3.7% | — | $962.56 | +11.7% |
| 1 year | -7.9% | — | $921.29 | +12.4% |
| 3 years | +72.3% | +19.9% | $1,723 | +88.5% |
| 5 years | -8.4% | -1.8% | $915.51 | +76.0% |
| 10 years | +325.9% | +15.6% | $4,259 | +316.6% |
ResMed return by calendar year
| Year | RMD | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -3.7% | +11.7% | -15.4% |
| 2025 | +6.3% | +17.7% | -11.5% |
| 2024 | +34.2% | +24.9% | +9.3% |
| 2023 | -16.5% | +26.2% | -42.7% |
| 2022 | -19.5% | -18.2% | -1.3% |
| 2021 | +23.4% | +28.7% | -5.3% |
| 2020 | +38.3% | +18.4% | +20.0% |
| 2019 | +37.9% | +31.2% | +6.6% |
| 2018 | +36.4% | -4.6% | +40.9% |
| 2017 | +39.1% | +21.7% | +17.4% |
| 2016 | +18.0% | +12.0% | +6.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RMD financials · RMD valuation
No forecast, no recommendation. This page describes ResMed from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.